Literature DB >> 20125191

High frequency of copy number imbalances in Rubinstein-Taybi patients negative to CREBBP mutational analysis.

Cristina Gervasini1, Federica Mottadelli, Roberto Ciccone, Paola Castronovo, Donatella Milani, Gioacchino Scarano, Maria Francesca Bedeschi, Serena Belli, Alba Pilotta, Angelo Selicorni, Orsetta Zuffardi, Lidia Larizza.   

Abstract

Rubinstein-Taybi syndrome (RSTS) is a rare autosomal dominant disorder characterised by facial dysmorphisms, growth and psychomotor development delay, and skeletal defects. The known genetic causes are point mutations or deletions of the CREBBP (50-60%) and EP300 (5%) genes. To detect chromosomal rearrangements indicating novel positional candidate RSTS genes, we used a-CGH to study 26 patients fulfilling the diagnostic criteria for RSTS who were negative at fluorescence in situ hybridisation analyses of the CREBBP and EP300 regions, and direct sequencing analyses of the CREBBP gene. We found seven imbalances (27%): four de novo and three inherited rearrangements not reported among the copy number variants. A de novo 7p21.1 deletion of 500 kb included the TWIST1 gene, a suggested candidate for RSTS that is responsible for the Saethre-Chotzen syndrome, an entity that enters in differential diagnosis with RSTS. A similar issue of differential diagnosis was raised by a large 4.3 Mb 2q22.3q23.1 deletion encompassing ZEB2, the gene responsible for the Mowat-Wilson syndrome, whose signs may overlap with RSTS. Positional candidate genes could not be sought in the remaining pathogenetic imbalances, because of the size of the involved region (a 9 Mb 2q24.3q31.1 deletion) and/or the relative paucity of suitable genes (a 5 Mb 3p13p12.3 duplication). One of the inherited rearrangements, the 17q11.2 379Kb duplication, represents the reciprocal event of the deletion underlying an overgrowth syndrome, both being mediated by the NF1-REP-P1 and REP-P2 sub-duplicons. The contribution of this and the other detected CNVs to the clinical RSTS phenotype is difficult to assess.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20125191      PMCID: PMC2987354          DOI: 10.1038/ejhg.2010.1

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  39 in total

1.  Molecular analysis of the CBP gene in 60 patients with Rubinstein-Taybi syndrome.

Authors:  I Coupry; C Roudaut; M Stef; M-A Delrue; M Marche; I Burgelin; L Taine; C Cruaud; D Lacombe; B Arveiler
Journal:  J Med Genet       Date:  2002-06       Impact factor: 6.318

2.  Overlap between Rubinstein-Taybi and Saethre-Chotzen syndromes: a case report.

Authors:  R B Lowry
Journal:  Am J Med Genet Suppl       Date:  1990

3.  Rubinstein-Taybi syndrome with deletions of FISH probe RT1 at 16p13.3: two UK patients.

Authors:  J M McGaughran; L Gaunt; J Dore; F Petrij; H G Dauwerse; D Donnai
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

4.  NF1 microdeletion breakpoints are clustered at flanking repetitive sequences.

Authors:  M O Dorschner; V P Sybert; M Weaver; B A Pletcher; K Stephens
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

5.  Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations.

Authors:  F Petrij; H G Dauwerse; R I Blough; R H Giles; J J van der Smagt; R Wallerstein; P D Maaswinkel-Mooy; C D van Karnebeek; G J van Ommen; A van Haeringen; J H Rubinstein; H M Saal; R C Hennekam; D J Peters; M H Breuning
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

6.  Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR.

Authors:  Isabelle Coupry; Laurence Monnet; Azza Abd El Moneim Attia; Laurence Taine; Didier Lacombe; Benoît Arveiler
Journal:  Hum Mutat       Date:  2004-03       Impact factor: 4.878

Review 7.  CBP and p300: HATs for different occasions.

Authors:  Eric Kalkhoven
Journal:  Biochem Pharmacol       Date:  2004-09-15       Impact factor: 5.858

Review 8.  Limb malformations and the human HOX genes.

Authors:  Frances R Goodman
Journal:  Am J Med Genet       Date:  2002-10-15

9.  Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP.

Authors:  F Petrij; R H Giles; H G Dauwerse; J J Saris; R C Hennekam; M Masuno; N Tommerup; G J van Ommen; R H Goodman; D J Peters
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

Review 10.  Tumors in Rubinstein-Taybi syndrome.

Authors:  R W Miller; J H Rubinstein
Journal:  Am J Med Genet       Date:  1995-03-13
View more
  4 in total

Review 1.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

Review 2.  The role of genetics in the establishment and maintenance of the epigenome.

Authors:  Covadonga Huidobro; Agustin F Fernandez; Mario F Fraga
Journal:  Cell Mol Life Sci       Date:  2013-03-10       Impact factor: 9.261

3.  Thyroid hypoplasia as a cause of congenital hypothyroidism in monozygotic twins concordant for Rubinstein-Taybi syndrome.

Authors:  Mustafa Ali Akın; Tamer Güneş; Leyla Akın; Dilek Çoban; Sena Kara Oncu; Aslıhan Kiraz; Selim Kurtoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011-02-23

4.  Is an analysis of copy number variants necessary for various types of kidney ultrasound anomalies in fetuses?

Authors:  Shaobin Lin; Shanshan Shi; Linhuan Huang; Ting Lei; Danlei Cai; Wenlong Hu; Yi Zhou; Yanmin Luo
Journal:  Mol Cytogenet       Date:  2019-07-05       Impact factor: 2.009

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.